Dimensional Fund Advisors’s Nephros NEPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.1K Buy
22,164
+1,419
+7% +$4.61K ﹤0.01% 3156
2026
Q1
$61.8K Buy
20,745
+7,144
+53% +$28.5K ﹤0.01% 3162
2025
Q4
$66.4K Hold
13,601
﹤0.01% 3195
2025
Q3
$64.3K Buy
+13,601
New +$53.4K ﹤0.01% 3228
2024
Q4
Sell
-14,875
Closed -$25.4K 3355
2024
Q3
$25.4K Sell
14,875
-2,756
-16% -$5.45K ﹤0.01% 3325
2024
Q2
$37.2K Buy
+17,631
New +$38K ﹤0.01% 3333

Other funds holding NEPH

Dimensional Fund Advisors's NEPH Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Nephros (NEPH) stake by 6.8% in Q2 2026, buying an estimated $4.61K and bringing the position to 22,164 shares worth $79.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3156.

Dimensional Fund Advisors first reported a position in NEPH in Q2 2024 and has held it in 6 quarters since. 33 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

  • Dimensional Fund Advisors held 22,164 shares of Nephros worth $79.1K as of Q2 2026.
  • Dimensional Fund Advisors bought 1,419 Nephros shares in Q2 2026, an estimated $4.61K.
  • Nephros made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3156 holding.
  • Dimensional Fund Advisors first reported a position in Nephros in Q2 2024 and has held it in 6 quarters since.
  • 33 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.